ORGAN

Autologous cellular implants for organ therapies

Lungs Fractal
Circle with tick clipart

 

PROVEN EFFECTIVE

Circle with arrow clipart

MINIMALLY INVASIVE

Thumbs Up Clipart

EASY AND ACCESSIBLE

World with tick clipart

UNDERGOING CLINICAL TRIAL

YOU ARE THE BEST TREATMENT

For years, the treatment for injured or damaged organs has been mostly linear. It begins with drugs designed to combat symptoms and slow further loss of function. Some organs respond better than others, but in many cases deterioration is followed eventually by more invasive treatments—dialysis for renal failure, for example—or even organ transplant. These procedures can be costly and often carry with them the unnecessary risk of complication, such as rejection of the transplant or serious infection.

The SVF-2 will soon make cellular therapy a safe, effective alternative. This procedure uses the patient’s own cells to create a healing environment within their body. The goal is to enable the body’s healing intelligence to repair damage and prevent further deterioration. Although the device and therapy are still undergoing a clinical trial, they show promise for a variety of organ therapies.

THE PROCESS IS SIMPLE

01

EXTRACT

Using the SVF-2, a small sample of adipose tissue is extracted from the patient.

02

WASH

Using the SVF-2, the adipose tissue is washed to remove red cells and other contaminants.

03

ISOLATE

From that tissue, we isolate a heterogenous mixture of the essential stromal and vascular cells that enable natural tissue repair and regeneration.

04

INJECT

The autologous cellular implant is then extracted from the SVF-2 device and then reintroduced into the body at site of damage.

In more severe cases, surgical intervention may still be required, but for many, this procedure may present a long-term, non-surgical, regenerative solution.

BLOG

Beyond drugs and Surgery: changing medicine as we know it

As a company committed to proving the promise of regenerative medicine, GID continues to evaluate applications of its SVF-2 cellular implant platform clinically. One such application is the treatment of…

BLOG

Initial safety and feasibility of cellular therapy

Companies and clinics tout the promise of cellular therapy (usually as a “stem cell therapy”) backed by little more than anecdotal evidence and the hypothetical possibility of efficacy. When we…

BLOG

Interventional orthopedics and cell based therapy

A total knee replacement involves hours of surgery, a metal/polymer implant, and months of recovery. We prefer a minimally invasive approach that uses an injection instead of surgery, a cellular…

Lungs Fractal

ORGAN

Autologous cellular implants for organ therapies

Circle with tick clipart

 

PROVEN EFFECTIVE

Circle with arrow clipart

MINIMALLY INVASIVE

Thumbs Up Clipart

EASY AND ACCESSIBLE

World with tick clipart

UNDERGOING CLINICAL TRIAL

YOU ARE THE BEST TREATMENT

For years, the treatment for injured or damaged organs has been mostly linear. It begins with drugs designed to combat symptoms and slow further loss of function. Some organs respond better than others, but in many cases deterioration is followed eventually by more invasive treatments—dialysis for renal failure, for example—or even organ transplant. These procedures can be costly and often carry with them the unnecessary risk of complication, such as rejection of the transplant or serious infection.

The SVF-2 will soon make cellular therapy a safe, effective alternative. This procedure uses the patient’s own cells to create a healing environment within their body. The goal is to enable the body’s healing intelligence to repair damage and prevent further deterioration. Although the device and therapy are still undergoing a clinical trial, they show promise for a variety of organ therapies.

THE PROCESS IS SIMPLE

01

EXTRACT

Using the SVF-2, a small sample of adipose tissue is extracted from the patient.

02

WASH

Using the SVF-2, the adipose tissue is washed to remove red cells and other contaminants.

03

ISOLATE

From that tissue, we isolate a heterogenous mixture of the essential stromal and vascular cells that enable natural tissue repair and regeneration.

04

INJECT

The autologous cellular implant is then extracted from the SVF-2 device and then reintroduced into the body at site of damage.

In more severe cases, surgical intervention may still be required, but for many, this procedure may present a long-term, non-surgical, regenerative solution.

BLOG

Beyond drugs and Surgery: changing medicine as we know it

As a company committed to proving the promise of regenerative medicine, GID continues to evaluate applications of its SVF-2 cellular implant platform clinically. One such application is the treatment of…

BLOG

Initial safety and feasibility of cellular therapy

Companies and clinics tout the promise of cellular therapy (usually as a “stem cell therapy”) backed by little more than anecdotal evidence and the hypothetical possibility of efficacy. When we…

BLOG

Interventional orthopedics and cell based therapy

A total knee replacement involves hours of surgery, a metal/polymer implant, and months of recovery. We prefer a minimally invasive approach that uses an injection instead of surgery, a cellular…